Sanofi to work with Curie on ovarian cancer targets

06/20/2013 | GenomeWeb Daily News (free registration)

Sanofi and the Curie Institute have agreed to cooperate in the search for new therapeutic targets for ovarian cancer using next-generation sequencing, reverse-phase protein analysis and patient-derived xenografts. The three-year collaboration seeks "to gain a better understanding of the molecular alterations that characterize many types of ovarian cancer, thereby enabling effective new drugs to be designed," the partners said.

View Full Article in:

GenomeWeb Daily News (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
CareFusion
Minneapolis, MN
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
In house Compliance Officer
Confidential
Pompano Beach, FL